Connect with us

TechCrunch

FindAir is a smart inhaler

FindAir is digitizing asthma therapy with smart inhaler technology. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech…

Published

on

FindAir is digitizing asthma therapy with smart inhaler technology.

The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education.

TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

Continue Reading
Advertisement
9 Comments

9 Comments

  1. Abhishek Rao Chimbili

    October 27, 2019 at 4:51 pm

    That is the most useless thing I’ve ever seen.

  2. Brandon S.

    October 27, 2019 at 4:52 pm

    You are supposed to use a spacer. The inhaler alone is not good. Not to mention there are some inhalers that already track the number of uses. This is pointless.

  3. Greg Nulik

    October 27, 2019 at 7:21 pm

    Hope the sensor supports a full dosage.

  4. polyannamoonbeam

    October 27, 2019 at 10:39 pm

    Not enough info …sensor tells you what your trigger was…? How? Blood prick analysis? Heartrate? Allergen analysis? Doctors are now instructed to ration patients to one Ventolin a month, two if you argue at length. There is no science to back up patients self diagnosed need for more, doctors differ on what is sufficient, how to measure severity and are often punitive/ biased against smokers. Many patients become resistant to their Ventolyn due to misuse, long term use.. tracking usage doesnt tell you whether patient needed to use more or less puffs for each event or just misused due to poor technique….severe attacks are not managed by Ventolin. Steroids,adrenalin, intravenous meds, full mask vaporised meds- we use all in winter for son.

  5. Pinitrius

    October 27, 2019 at 11:34 pm

    Being an allergist I was interested to see what this was about… But no! It gives some information about patient adherence to the treatment but as with many products/service it is trying to force a subscription down patients throat without providing real long term value! And the product itself is rendered useless after 12 months due to the non-removable battery!

    To me it is just a gimmick the way they chose to make it and charge for it! Sorry…

  6. TechPimp

    October 28, 2019 at 1:51 am

    I didn’t understand what the heck it does?

  7. Gezaei Teklay

    October 28, 2019 at 2:09 am

    I hope it is helpful for asthma

  8. Arthur

    October 28, 2019 at 9:12 am

    So it counts how many times you use an inhaler a day and displays it on an app?

  9. takeonparis

    October 29, 2019 at 12:15 am

    This is the dumbest interview I’ve ever seen. He doesn’t even bother to ask: “So what does your product DO?” Like what in the actual hell…

Leave a Reply

Your email address will not be published. Required fields are marked *

Science & Technology

Black Founders Had a Great Fundraising Quarter…With a Catch

On one hand, US-based, Black-founded startups have already raised $643M, 70% of what was raised in the entirety of last year. But dig a little deeper into the numbers, and you’ll find that in the words of Crunchbase’s head of research: “…data has shown a persistent decline in funding to Black-founded companies that outpaces the…

Published

on

On one hand, US-based, Black-founded startups have already raised $643M, 70% of what was raised in the entirety of last year.

But dig a little deeper into the numbers, and you’ll find that in the words of Crunchbase’s head of research: “…data has shown a persistent decline in funding to Black-founded companies that outpaces the overall decline in startup funding.”

Continue Reading

Science & Technology

SpaceX’s IPO Made Elon Musk a Trillionaire…Now What?│Equity Podcast

The biggest IPO in history dropped this morning on the Nasdaq — a debut so big, our team thought it deserved its own bonus Equity podcast episode. On this special bonus episode of TechCrunch’s Equity podcast, Senior Reporter Sean O’Kane called up our AI Editor Russell Brandom to help him break down the $2 trillion…

Published

on

The biggest IPO in history dropped this morning on the Nasdaq — a debut so big, our team thought it deserved its own bonus Equity podcast episode.

On this special bonus episode of TechCrunch’s Equity podcast, Senior Reporter Sean O’Kane called up our AI Editor Russell Brandom to help him break down the $2 trillion valuation, Elon Musk becoming the world’s first trillionaire, and what it all means for Anthropic and OpenAI still waiting in the wings.

Continue Reading

Science & Technology

AI’s Already Reshaped the Economy. Now We See What Happens Next │ Equity Podcast

No matter how viable it may be in the long term, AI has already reshaped the economy in expected,and unexpected, ways. The latest Equity podcast dives right in as we enter the OpenAI and Anthropic IPO frenzy this summer:

Published

on

No matter how viable it may be in the long term, AI has already reshaped the economy in expected,and unexpected, ways.

The latest Equity podcast dives right in as we enter the OpenAI and Anthropic IPO frenzy this summer:

Continue Reading

Trending